脑部放疗,上午比下午敏感许多!
. \. p% \* @& q6 h) n3 c: m
8 n5 W9 A" r) e% d8 \- r
9 S5 h. v/ i4 r+ y4 RCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.: v, s8 V) \7 N D$ [+ D0 C
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
4 @3 ?# ]% B5 g) DRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.5 ^0 N. e2 B! a$ ?* D( j" H& G
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
; Q4 v$ U: B" ^* L/ ~7 n9 s
6 n2 J7 G2 R7 E7 c; aAbstract
$ A7 l; ^1 P& o2 ? F8 v+ G+ ?3 ~2 ?BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.3 f/ a; g$ m( J7 d& l0 [+ h2 S) k
5 u2 ]' C' @2 E3 b6 e
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
* u+ z# {0 z' O" U! b: [' F& }' r* W9 w5 S, X2 d4 a& s
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
6 { Y" M7 D$ o) R0 c5 {4 O. r t; B
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
8 E$ y+ E, e8 V
, d9 R o4 i, v" X |